Product Information
CETIRIZINE HCL 10 MG TABLET is a generic product labeled by BluePoint Laboratories, priced at $0.0640 per EA under NDC 68001043697. Its NADAC has been published 277 times since Mar 10, 2021.
Strength
10 mg/1
Manufacturer
BluePoint LaboratoriesNDC
68001043697
Classification
Generic
Dosage Form
TABLET
Route
ORAL
Last Updated
6/17/2026
Active Ingredients
CETIRIZINE HYDROCHLORIDEApproval Type
Generic (ANDA)
FDA Application
ANDA090760On Market Since
6/19/2020
Pharmacological Classes
Price Statistics
The NADAC for CETIRIZINE HCL 10 MG TABLET has been published 277 times since Mar 10, 2021, and over the history we have for it it has declined 8.4%. The table below summarizes its recorded NADAC range and movement.
| Current price | $0.0640 per EA |
|---|---|
| All-time high | $0.0805 (Jul 14, 2021) |
| All-time low | $0.0539 (Jul 17, 2024) |
| 52-week high | $0.0721 |
| 52-week low | $0.0602 |
| Median price | $0.0673 |
| Average price | $0.0669 |
| Largest weekly change | +24.2% (Aug 21, 2024) |
| Weeks tracked | 277 |
| Tracking since | Mar 10, 2021 |
Generic Alternatives
The matcher finds 16 NADAC-published products sharing this drug's active ingredient, strength, and dosage form across 10 manufacturers (up to 10 shown below). None of the shown alternatives sit below the current price. These are candidates to verify clinically, not guaranteed substitutes — see our generic drug prices guide.
Frequently asked questions
What is the NADAC price of CETIRIZINE HCL 10 MG TABLET?
The current National Average Drug Acquisition Cost (NADAC) for CETIRIZINE HCL 10 MG TABLET, manufactured by BluePoint Laboratories, is $0.0640 per EA (NDC 68001043697), effective Jun 24, 2026.
How has the price of CETIRIZINE HCL 10 MG TABLET changed over time?
Over the history we have for it, the NADAC for CETIRIZINE HCL 10 MG TABLET has declined 8.4%. It has been tracked across 277 weekly CMS publications since Mar 10, 2021.
What are the highest and lowest recorded NADAC prices for CETIRIZINE HCL 10 MG TABLET?
Since Mar 10, 2021, the NADAC for CETIRIZINE HCL 10 MG TABLET has ranged from a low of $0.0539 (Jul 17, 2024) to a high of $0.0805 (Jul 14, 2021), with a median of $0.0673 per EA.
Are there cheaper alternatives to CETIRIZINE HCL 10 MG TABLET?
16 NADAC-published products share the same active ingredient, strength, and dosage form as CETIRIZINE HCL 10 MG TABLET, but none are currently priced below it.
Who manufactures CETIRIZINE HCL 10 MG TABLET?
CETIRIZINE HCL 10 MG TABLET (NDC 68001043697) is labeled by BluePoint Laboratories, and CMS classifies it as a generic product.
Related Drugs
Same classification